Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dacarbazine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT03430297
What this trial is testing

A Randomized, Controlled, Multi-center, Phase III Clinical Study to Investigate Recombinant Humanized PD-1 Monoclonal Antibody Injection (JS001) Versus Dacarbazine as the 1st-line Therapy for Unresectable or Metastatic Melanoma

Who this might be right for
Metastatic MelanomaUnresectable Melanoma
Shanghai Junshi Bioscience Co., Ltd. 256
Early research (Phase 1)Study completedNCT00179608
What this trial is testing

Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Previously Untreated With Systemic Chemotherapy

Who this might be right for
Malignant Melanoma
Celgene 28
Testing effectiveness (Phase 2)Study completedNCT00246012
What this trial is testing

A Safety and Efficacy Study of Intetumumab, Alone and in Combination With Dacarbazine, in Participants With Stage 4 Melanoma

Who this might be right for
Melanoma
Centocor, Inc. 144
Not applicableStudy completedNCT07171827
What this trial is testing

Anti-CD30 (Brentuximab Vedotin) With AVD Versus ABVD Chemotherapy Protocol Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma

Who this might be right for
Anti-CD30BrentuximabDoxorubicin+4 more
Helwan University 60
Testing effectiveness (Phase 2)Study completedNCT03331341
What this trial is testing

Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
University of Washington 50
Not applicableStudy completedNCT01868451
What this trial is testing

Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Memorial Sloan Kettering Cancer Center 118
Early research (Phase 1)Study completedNCT03761095
What this trial is testing

Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)

Who this might be right for
Leiomyosarcoma
PTC Therapeutics 41
Testing effectiveness (Phase 2)Study completedNCT00911443
What this trial is testing

Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma

Who this might be right for
Malignant Melanoma
sigma-tau i.f.r. S.p.A. 488
Large-scale testing (Phase 3)Study completedNCT00003647
What this trial is testing

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Stage IV MelanomaStage III MelanomaRecurrent Melanoma
Vical
Large-scale testing (Phase 3)Study completedNCT01359956
What this trial is testing

Fotemustine and Dacarbazine Versus Dacarbazine +/- Alpha Interferon in Advanced Malignant Melanoma

Who this might be right for
Malignant MelanomaRecurrent Melanoma
National Cancer Institute, Naples 269
Testing effectiveness (Phase 2)UnknownNCT02994498
What this trial is testing

Safety and Efficacy of DCB-BO1301 in Advanced Melanoma

Who this might be right for
Advanced Melanoma
Chung Mei Biopharma Co., Ltd 33
Testing effectiveness (Phase 2)UnknownNCT01614301
What this trial is testing

Phase I and Consecutive Phase II, Two-arm, Randomized Multi-center Trial in Patients With Advanced Melanoma

Who this might be right for
Advanced Melanoma
University of Regensburg 136
Large-scale testing (Phase 3)Study completedNCT00518895
What this trial is testing

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Who this might be right for
Melanoma
Genta Incorporated 300
Testing effectiveness (Phase 2)Study completedNCT00597038
What this trial is testing

A Phase I/II Study of Dasatinib and Dacarbazine

Who this might be right for
Metastatic Melanoma
H. Lee Moffitt Cancer Center and Research Institute 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04067037
What this trial is testing

Camrelizumab Combined With AVD in the First-line Treatment for Patients With Advanced Classical Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Henan Cancer Hospital 60
Large-scale testing (Phase 3)Study completedNCT01692678
What this trial is testing

Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Who this might be right for
Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Xian-Janssen Pharmaceutical Ltd. 16
Testing effectiveness (Phase 2)UnknownNCT05900765
What this trial is testing

Zimberelimab(GLS-010) Combined With AVD for Newly Diagnosed Early-stage Hodgkin's Lymphoma

Who this might be right for
Classical Hodgkin Lymphoma
Sun Yat-sen University 54
Large-scale testing (Phase 3)Ended earlyNCT01280565
What this trial is testing

Masitinib in Non-Resectable or Metastatic Stage 3/4 Melanoma Carrying a Mutation in the Juxta Membrane Domain of c-Kit

Who this might be right for
Metastatic Melanoma
AB Science 134
Large-scale testing (Phase 3)Active Not RecruitingNCT06346067
What this trial is testing

Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2)

Who this might be right for
Advanced or Metastatic NRAS-mutant Melanoma
Erasca, Inc. 78
Testing effectiveness (Phase 2)Looking for participantsNCT07002216
What this trial is testing

BrECADD Therapy in Stage 2 B-IV Hodgkin Lymphoma

Who this might be right for
Hodgkin LymphomaAdvanced Hodgkin Lymphoma
University of Miami 48
Next Page